MIF and Sepsis: Further research involving in vivo models, such as examining CSN6 and MIF expression levels in macrophages or monocytes from sepsis and control mice, is essential to fully confirm these findings and establish the therapeutic potential of targeting the CSN6/MIF axis in sepsis.